Litcius/Paper detail

Pharmacokinetics of amoxicillin in obese and nonobese subjects

Ana Luiza Pelissari Pessanha de Paula Soares, Maiara Camotti Montanha, Conrado de Souza Alcantara, Sandra R.B. Silva, Cristina Megumi Kuroda, Sérgio Yamada, Antônio Eduardo Nicácio, Liane Maldaner, Jesuı́ V. Visentainer, Caroline Ferraz Simões, João Carlos Locatelli, Wendell Arthur Lopes, Josmar Mazucheli, Andréa Diniz, Paulo Paixão, Elza Kimura

2021British Journal of Clinical Pharmacology23 citationsDOIOpen Access PDF

Abstract

Aims To compare the pharmacokinetics of amoxicillin (AMX) in obese and nonobese subjects, given as single dose 875‐mg tablets. Methods A prospective, single‐centre, open‐label, clinical study was carried out involving 10 nonobese and 20 obese subjects given a dose of an AMX 875‐mg tablet. Serial blood samples were collected between 0 and 8 hours after administration of AMX and plasma levels were quantified by liquid chromatography–tandem mass spectrometry. The pharmacokinetic parameters (PK) were calculated by noncompartmental analysis and means of the 2 groups were compared using Student t‐ test. Analysis of correlation between covariates and PK was performed using Pearson's correlation coefficient. Results Ten nonobese subjects (mean age 30.6 ± 7.12 y; body mass index 21.56 ± 1.95 kg/m 2 ) and 20 obese subjects (mean age 34.47 ± 7.03 y; body mass index 33.17 ± 2.38 kg/m 2 ) participated in the study. Both maximum concentration (C max ; 12.12 ± 4.06 vs . 9.66 ± 2.93 mg/L) and area under the curve (AUC) 0‐inf (34.18 ± 12.94 mg.h/L vs . 26.88 ± 9.24 mg.h/L) were slightly higher in nonobese than in obese subjects, respectively, but differences were not significant. The volume of distribution (V/F) parameter was statistically significantly higher in obese compared to nonobese patients (44.20 ± 17.85 L vs . 27.57 ± 12.96 L). Statistically significant correlations were observed for several weight metrics vs . AUC, C max , V/F and clearance, and for creatinine clearance vs . AUC, C max and clearance. Conclusion In obese subjects, the main altered PK was V/F as a consequence of greater body weight. This may result in antibiotic treatment failure if standard therapeutic regimens are administered.

Topics & Concepts

AmoxicillinPharmacokineticsMedicineInternal medicinePharmacologyAntibioticsChemistryBiochemistryAntibiotics Pharmacokinetics and EfficacyPharmacology and Obesity TreatmentPharmaceutical Quality and Counterfeiting